US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.15

+0.76232.69%

Post-market: 29.220.0677+0.23%19:30 EDT

Volume:10.21K

Turnover:295.42K

Market Cap:30.61M

PE:- -

High:29.22

Open:28.51

Low:28.51

Close:28.39

52wk High:33.59

52wk Low:23.00

Shares:1.05M

Float Shares:1.05M

Volume Ratio:2.66

T/O Rate:0.97%

Dividend:0.07

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Iqvia. - Notes to Bear 6.375% Interest, Payable Semi-Annually from March 15, 2027

THOMSON REUTERS

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology

Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent

Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology

THOMSON REUTERS

IQVIA backs real world pegcetacoplan study in rare kidney disease

Tempus AI Initiated at Neutral by UBS

UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target

MT Newswires Live

IQVIA Plans USD 2 Billion Senior Notes Offering Due 2034

Iqvia. - Proceeds to Redeem Senior 5.000% Notes Due 2026 and Repay Revolving Credit Facility

THOMSON REUTERS

Iqvia. - to Offer $2 Bln Senior Notes Due 2034

THOMSON REUTERS

BrainAurora defines optimal pediatric doses for cognitive digital therapeutics in major BMC Medicine study

IQVIA Sees U.S. MASH Diagnostics Using Genfit Technology Topping USD 1.5 Billion Sales by 2033

Centene Corp. Stock Underperforms Tuesday When Compared to Competitors

Gartner Inc. Stock Slips 7.4%, Underperforms Peers

ABL Diagnostics Delivers Surging Profits as Scale‑Up Strategy Takes Hold

Tempus AI Price Target Announced at $67.00/Share by Roth Capital

Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target

MT Newswires Live

Did Dexcom, Inc. Insiders Breach Their Fiduciary Duties to Shareholders?

THOMSON REUTERS

Vitura hit by BUPA telehealth shift but reiterates FY2027 growth outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/HEAL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HEAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","market":"US","secType":"STK","nameCN":"Global X HealthTech ETF","latestPrice":29.1523,"timestamp":1789416000000,"preClose":28.39,"halted":0,"volume":10209,"hourTrading":{"tag":"盘后","latestPrice":29.22,"preClose":29.1523,"latestTime":"19:30 EDT","volume":14,"amount":408.8338,"timestamp":1789428601106,"change":0.0677,"changeRate":0.002322,"amplitude":0},"delay":0,"changeRate":0.026851003874603725,"floatShares":1049843,"shares":1049843,"eps":0,"marketStatus":"Not Yet Opened","change":0.7623,"latestTime":"09-14 16:00:00 EDT","open":28.51,"high":29.22,"low":28.51,"amount":295420.936536,"amplitude":0.025009,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":28.39,"sharesOutstanding":1329868,"nav":28.47,"aum":29885097.39,"dividendRate":0.002442,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29.22,"preClose":29.1523,"latestTime":"19:30 EDT","volume":14,"amount":408.8338,"timestamp":1789428601106,"change":0.0677,"changeRate":0.002322,"amplitude":0},"volumeRatio":2.657348,"impliedVol":0.1814,"impliedVolPercentile":0.592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","floatShares":1049843,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.657348,"shares":1049843,"dividePrice":0.0712,"high":29.22,"amplitude":0.025009,"preClose":28.39,"low":28.51,"week52Low":23,"pbRate":"--","week52High":33.59,"institutionHeld":0,"latestPrice":29.1523,"eps":0,"divideRate":0.002442,"volume":10209,"delay":0,"ttmEps":0,"open":28.51,"prevYearClose":29.215,"prevWeekClose":28.39,"prevMonthClose":29.6135,"prevQuarterClose":27.59,"fiveDayClose":29.615,"twentyDayClose":29.245,"sixtyDayClose":25.6011},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HEAL\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HEAL","amount":0.071843,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"HEAL","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":3,"toFactor":1,"ratio":3},{"date":"2025-06-27","symbol":"HEAL","amount":0.00815,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HEAL\",market:\"US\",,,undefined,":[{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00815,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.071843,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HEAL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HEAL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666558389","title":"Iqvia. - Notes to Bear 6.375% Interest, Payable Semi-Annually from March 15, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558389","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558389?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:13","pubTimestamp":1788988380,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUABJKPVY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0477156797.USD","BK4121","LU0130103400.USD","LU0130102774.USD","BK4588","BK4585","LU0980610538.SGD","HEAL","LU1791710400.SGD","LU0528227936.USD","LU1989764748.USD","BK4530","LU0882574055.USD","LU0198837287.USD","LU1989764664.SGD","LU1261432733.SGD","LU0130518102.USD","LU0648000940.SGD","IQV","LU0130517989.USD","LU0477156953.USD","LU0648001328.SGD","LU1201861165.SGD","LU1791710582.SGD","EKG","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530728","title":"Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530728","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530728?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:01","pubTimestamp":1788987660,"startTime":"0","endTime":"0","summary":"DJ Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Labcorp Holdings Inc.  slid 1.16% to $321.10 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,636.36 and Dow Jones Industrial Average  falling 0.77% to 52,380.66.This was the stock's fourth consecutive day of losses.Labcorp Holdings Inc. closed 6.05% below its 52-week high of $341.80, which the company reached on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as IQVIA Holdings Inc.  fell 0.86% to $256.98, Centene Corp.  fell 0.81% to $64.06, and Teladoc Health Inc.  fell 2.56% to $6.10.Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","LU2065171402.SGD","LU0742534661.SGD","LU2362541513.USD","LU1291159041.SGD","LU1699723380.USD","LU1861558580.USD","LU0648000940.SGD","LU0130517989.USD","IQV","TDOC","LU2362540622.SGD","BK4196","LU0251142724.SGD","LU2065170008.USD","BK4167","LU0859254822.USD","IE0034235188.USD","LU0648001328.SGD","LU1989764748.USD","BK4530","LU1201861165.SGD","LU1059921491.USD","EKG","HEAL","LU0006061336.USD","LU0882574055.USD","BK4585","LU1791710400.SGD","LU0528227936.USD","LU1791710582.SGD","CNC","BK4567","LU0130518102.USD","LU1261432733.SGD","LU0477156797.USD","LU2065169927.USD","BK4504","BK4534","CNCG","BK4548","LH","LU0048573561.USD","LU0477156953.USD","LU2065171311.SGD","LU2237438978.USD","LU1989771016.USD","LU0130103400.USD","LU0198837287.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530872","title":"Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530872","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530872?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:05","pubTimestamp":1788984341,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced that it has been selected by the Advanced Research Projects Agency for Health, an agency within the U.S. Department of He...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-awarded-up-to-9-5m-from-arpa-h-for-autonomous-ai-in-cardiology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-awarded-up-to-9-5m-from-arpa-h-for-autonomous-ai-in-cardiology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEMC","TEM","HEAL","BK4121","BK4613","ARKG","LU1861558580.USD","TEMT","LU1861559042.SGD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371155","title":"Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371155","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371155?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984085,"startTime":"0","endTime":"0","summary":"Tempus AI wins up to $9.5 million ARPA-H ADVOCATE award for autonomous heart failure agentTempus AI won up to USD 9.5 million from the US Department of Health and Human Services’ ARPA-H ADVOCATE progr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL94GQX6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","ARKG","LU1861559042.SGD","TEMC","TEM","HEAL","TEMT","BK4121","BK4613","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666164537","title":"Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666164537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666164537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984074,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510GH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4611","LU1861559042.SGD","TEM","HEAL","TEMC","TEMT","BK4613","LU1861558580.USD","BK4121","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666683534","title":"IQVIA backs real world pegcetacoplan study in rare kidney disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2666683534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666683534?lang=en_us&edition=fundamental","pubTime":"2026-09-10 00:31","pubTimestamp":1788971485,"startTime":"0","endTime":"0","summary":"IQVIA Holdings ($IQV) announced an update on their ongoing clinical study. The study “Real-World Effectiveness and Safety of Pegcetacoplan in Patie...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iqvia-backs-real-world-pegcetacoplan-study-in-rare-kidney-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iqvia-backs-real-world-pegcetacoplan-study-in-rare-kidney-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0477156797.USD","LU1791710400.SGD","BK4121","EKG","LU0477156953.USD","LU1989764748.USD","IQV","LU1989764664.SGD","LU0130518102.USD","LU1261432733.SGD","LU1791710582.SGD","LU0648001328.SGD","LU0648000940.SGD","LU0130103400.USD","BK4588","LU0882574055.USD","LU0130102774.USD","LU0980610538.SGD","LU1201861165.SGD","LU1201861249.SGD","BK4585","HEAL","BK4530","LU0528227936.USD","LU0198837287.USD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536365","title":"Tempus AI Initiated at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536365","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536365?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:35","pubTimestamp":1788960900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4121","ARKG","TEM","LU1861558580.USD","HEAL","TEMC","TEMT","LU1861559042.SGD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666382905","title":"UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666382905","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666382905?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:17","pubTimestamp":1788956270,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $66.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARKG","BK4613","HEAL","LU1861558580.USD","TEMT","BK4611","LU1861559042.SGD","BK4121","TEMC","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666286538","title":"IQVIA Plans USD 2 Billion Senior Notes Offering Due 2034","url":"https://stock-news.laohu8.com/highlight/detail?id=2666286538","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666286538?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:15","pubTimestamp":1788956155,"startTime":"0","endTime":"0","summary":"IQVIA plans USD 2 billion senior notes offering due 2034IQVIA Holdings announced an offering of USD 2 billion senior notes due 2034 via subsidiary IQVIA Inc.Proceeds earmarked to redeem IQVIA Inc.’s 5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLbFQlkq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4121","BK4530","LU1201861165.SGD","LU0130102774.USD","LU0648001328.SGD","BK4585","IQV","LU0130517989.USD","EKG","LU1989764748.USD","LU0130518102.USD","LU1791710400.SGD","LU0130103400.USD","LU1989764664.SGD","LU0477156797.USD","LU0882574055.USD","LU0477156953.USD","LU1201861249.SGD","LU0198837287.USD","LU0528227936.USD","LU1261432733.SGD","LU0980610538.SGD","LU1791710582.SGD","HEAL","LU0648000940.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538479","title":"Iqvia. - Proceeds to Redeem Senior 5.000% Notes Due 2026 and Repay Revolving Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538479?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:15","pubTimestamp":1788956100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA2K7PSX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0130517989.USD","LU0882574055.USD","LU1791710400.SGD","BK4530","HEAL","LU0477156797.USD","LU0130518102.USD","LU0130103400.USD","BK4588","LU0130102774.USD","LU1201861165.SGD","LU0648000940.SGD","BK4121","LU0648001328.SGD","EKG","LU0198837287.USD","LU1261432733.SGD","LU0528227936.USD","LU1989764664.SGD","LU0980610538.SGD","BK4585","LU1989764748.USD","LU1201861249.SGD","LU1791710582.SGD","IQV","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538424","title":"Iqvia. - to Offer $2 Bln Senior Notes Due 2034","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538424?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:15","pubTimestamp":1788956100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA2K7PSX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0648000940.SGD","LU0198837287.USD","LU1261432733.SGD","LU1791710400.SGD","BK4530","BK4588","LU0130517989.USD","LU0477156797.USD","LU0528227936.USD","LU1201861165.SGD","BK4121","IQV","LU0477156953.USD","LU1989764748.USD","EKG","LU0130518102.USD","LU0980610538.SGD","LU0130103400.USD","HEAL","BK4585","LU0130102774.USD","LU1201861249.SGD","LU1989764664.SGD","LU1791710582.SGD","LU0648001328.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589947","title":"BrainAurora defines optimal pediatric doses for cognitive digital therapeutics in major BMC Medicine study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589947?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:10","pubTimestamp":1788945048,"startTime":"0","endTime":"0","summary":"BrainAurora Medical Technology Limited ( ($HK:6681) ) just unveiled an update. BrainAurora Medical Technology has reported the publication of a maj...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/brainaurora-defines-optimal-pediatric-doses-for-cognitive-digital-therapeutics-in-major-bmc-medicine-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/brainaurora-defines-optimal-pediatric-doses-for-cognitive-digital-therapeutics-in-major-bmc-medicine-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EKG","FDHT","HEAL","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666172302","title":"IQVIA Sees U.S. MASH Diagnostics Using Genfit Technology Topping USD 1.5 Billion Sales by 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2666172302","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666172302?lang=en_us&edition=fundamental","pubTime":"2026-09-09 13:30","pubTimestamp":1788931854,"startTime":"0","endTime":"0","summary":"IQVIA sees U.S. MASH diagnostics using Genfit technology topping USD 1.5 billion sales by 2033Genfit flagged U.S. peak sales above USD 1.5 billion by 2033 for MASH diagnostics using its NIS technology","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6ZcWSg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4121","BK4530","LU2210149790.SGD","BK4550","LU1201861165.SGD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU0314104364.USD","LU0130102774.USD","LU0006061336.USD","LU0648001328.SGD","BK4585","LU2237438978.USD","IQV","LU1059921491.USD","LH","LU0130517989.USD","IE00B64PRP62.GBP","BCDF","SG9999014013.SGD","IE00BN0W2T93.GBP","LU0251131958.USD","LU1791710400.SGD","SG9999014005.SGD","LU0130103400.USD","LU2095319765.USD","LU2210150020.SGD","LU1989764664.SGD","LU0648000940.SGD","IE00B3QW5Z07.USD","LU0477156797.USD","LU0882574055.USD","NDAQ","LU0477156953.USD","BK4196","IE00BN0W2W23.USD","SG9999014039.USD","LU1201861249.SGD","LU0251142724.SGD","IE00BGHQF748.EUR","LU0198837287.USD","LU0528227936.USD","LU1261432733.SGD","LU0980610538.SGD","SG9999014021.USD","IE00BKPKM429.USD","HEAL","EKG","LU0048573561.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666703203","title":"Centene Corp. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666703203","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666703203?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:57","pubTimestamp":1788901020,"startTime":"0","endTime":"0","summary":"DJ Centene Corp. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Centene Corp.  slid 3.67% to $64.58 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Centene Corp. closed 6.88% short of its 52-week high of $69.36, which the company achieved on July 14th.The stock underperformed when compared to some of its competitors Tuesday, as HCA Healthcare Inc.  fell 0.74% to $402.02, IQVIA Holdings Inc.  fell 3.20% to $259.21, and Labcorp Holdings Inc.  fell 0.62% to $324.86.Trading volume  remained 204,945 below its 50-day average volume of 4.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNC","LU0130518102.USD","SG9999014021.USD","LU0068578508.USD","LU0006061336.USD","LU0187121727.USD","BK4154","LH","LU0114720955.EUR","LU1267930573.SGD","HCA","LU0648001328.SGD","LU1989771016.USD","LU2065170008.USD","LU0477156797.USD","BK4530","LU0130517989.USD","LU1989764748.USD","CNCG","LU2362541513.USD","LU1150488218.USD","LU0203345920.USD","IQV","LU2362541273.HKD","BK4550","LU0433182093.SGD","LU0868494617.USD","BK4588","LU0708994859.HKD","LU1489326972.SGD","LU2362540622.SGD","LU0648000940.SGD","SG9999014005.SGD","IHF","LU0211328371.USD","LU0130103400.USD","LU0477156953.USD","LU1150488135.SGD","HEAL","LU0211327993.USD","LU1261432733.SGD","LU0048573561.USD","LU0128525929.USD","LU1791710582.SGD","LU0251142724.SGD","LU1267930490.SGD","EKG","LU2355687059.USD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666137749","title":"Gartner Inc. Stock Slips 7.4%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666137749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666137749?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:34","pubTimestamp":1788899640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Gartner Inc. slid 7.4% to $172.59 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,673.52 and Dow Jones Industrial Average falling 1.2% to 52,786.07.This was the stock's second consecutive day of losses.Gartner Inc. closed 35.1% below its 52-week high of $265.85, which the company reached on September 26th.The stock underperformed when compared to some of its peers, as Trade Desk Inc. Cl A fell 2.8% to $14.02, IQVIA Holdings Inc. fell 3.2% to $259.21, and Omnicom Group Inc. fell 1.80% to $81.13.Trading volume totaled 1.5 million, compared to the 50-day average of 1.4 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","LU0130517989.USD","LU1720051017.SGD","LU1201861249.SGD","LU0130102774.USD","LU0321505868.SGD","LU2517655028.SGD","IT","LU0477156953.USD","BK4585","LU1814569148.SGD","LU1989764664.SGD","LU1599440770.SGD","LU0731783394.SGD","BK4023","LU0648001328.SGD","LU2362541513.USD","LU2517655291.USD","TTDU","LU0130518102.USD","TTD","IE00BFXG1179.USD","BK4009","LU1509826696.USD","RSPC","HEAL","BK4121","LU0731783048.USD","LU0882574055.USD","LU1548497426.USD","BK4530","LU1261432733.SGD","LU1481011671.HKD","LU1989764748.USD","LU0528227936.USD","LU0648000940.SGD","BK4588","LU0154245673.USD","LU2362540622.SGD","LU0348723411.USD","LU0321505439.SGD","BK4613","BK4548","IQV","LU1481011911.USD","OMC","LU0198837287.USD","LU0477156797.USD","LU1201861165.SGD","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374809","title":"ABL Diagnostics Delivers Surging Profits as Scale‑Up Strategy Takes Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374809","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374809?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:05","pubTimestamp":1788887115,"startTime":"0","endTime":"0","summary":"The latest announcement is out from ABL Diagnostics SA ( ($FR:ABLD) ). ABL Diagnostics SA, a molecular diagnostics and healthcare software speciali...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-delivers-surging-profits-as-scaleup-strategy-takes-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-delivers-surging-profits-as-scaleup-strategy-takes-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IGM","HELX","IXJ","CGCV","ABLD","BK4588","NOBL","BK4550","EKG","QQH","TCAF","VGT","VHT","HEAL","BMED","BK4585","GNMX","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378451","title":"Tempus AI Price Target Announced at $67.00/Share by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378451","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378451?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:34","pubTimestamp":1788870840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","TEM","TEMC","LU1861559042.SGD","BK4121","TEMT","ARKG","HEAL","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321422","title":"Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321422","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665321422?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:12","pubTimestamp":1788862369,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $66.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HEAL","BK4121","LU1861559042.SGD","TEMT","LU1861558580.USD","TEMC","BK4613","TEM","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665310482","title":"Did Dexcom, Inc. Insiders Breach Their Fiduciary Duties to Shareholders?","url":"https://stock-news.laohu8.com/highlight/detail?id=2665310482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665310482?lang=en_us&edition=fundamental","pubTime":"2026-09-08 03:27","pubTimestamp":1788809220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUA3WLXPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210149790.SGD","LU2125909593.SGD","LU2210150020.SGD","LU1323610961.USD","BK4548","IE00BMPRXR70.SGD","LU0266013472.USD","LU0354030438.USD","LU2125909247.SGD","LU2211815571.USD","BK4082","BK4588","BK4551","LU1923622614.USD","BK4585","HEAL","BK4504","GB00BDT5M118.USD","IE00BMPRXN33.USD","LU2433249047.HKD","EKG","LU0354030511.USD","BK4534","DXCM","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314395","title":"Vitura hit by BUPA telehealth shift but reiterates FY2027 growth outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314395","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665314395?lang=en_us&edition=fundamental","pubTime":"2026-09-07 10:17","pubTimestamp":1788747434,"startTime":"0","endTime":"0","summary":"Cronos Australia Ltd. ( ($AU:VIT) ) just unveiled an announcement. Vitura Health has disclosed a material setback for its Doctors on Demand telehea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vitura-hit-by-bupa-telehealth-shift-but-reiterates-fy2027-growth-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vitura-hit-by-bupa-telehealth-shift-but-reiterates-fy2027-growth-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","HEAL","HTEC","LGHT","FDIF","EKG","ANEW","GDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}